List of insiders holdings for Immunome Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Barchas Isaac Director | 2024-08-21 16:05:23 | 2,626,792 0 | 2,626,792 | Form 13D |
| RAPP MICHAEL Director | 2023-10-03 17:50:48 | 1,071,172 208,742 | 1,279,914 | Form 4 |
| SIEGALL CLAY B President and CEO | 2024-11-25 08:41:00 | 519,636 0 | 519,636 | Form 4 |
| MORRIS I WISTAR III 10% Owner | 2022-02-14 13:21:37 | 386,064 0 | 386,064 | Form 13G |
| Morin Michael Chief Scientific Officer | 2020-10-01 21:31:01 | 377,342 0 | 377,342 | Form 3 |
| Roberts Phil Noland Chief Technology Officer | 2023-12-15 19:28:11 | 275,000 0 | 275,000 | Form 4 |
| Stoneman Sandra G. CHIEF LEGAL OFFICER & GC | 2024-08-13 17:54:10 | 210,000 0 | 210,000 | Form 4 |
| PRENDERGAST FRANKLYN G Director | 2023-10-04 17:28:38 | 198,565 0 | 198,565 | Form 4 |
| Higgins Jack Chief Scientific Officer | 2024-08-19 21:05:08 | 192,569 0 | 192,569 | Form 4 |
| Sarma Purnanand D President and CEO | 2023-06-12 16:56:18 | 166,500 0 | 166,500 | Form 4 |
| Rosett Max Chief Financial Officer | 2024-09-20 19:26:16 | 139,324 0 | 139,324 | Form 4 |
| Horn Kinney CHIEF BUSINESS OFFICER | 2024-08-13 17:51:22 | 130,000 0 | 130,000 | Form 4 |
| Fitzgerald Richard F Chief Financial Officer | 2020-10-05 16:40:59 | 112,483 0 | 112,483 | Form 4 |
| Turner Bruce Chief Strategy Officer | 2024-08-13 17:48:33 | 110,000 0 | 110,000 | Form 4 |
| ROBINSON MATTHEW K Chief Technology Officer | 2023-06-12 16:57:41 | 58,000 0 | 58,000 | Form 4 |
| Roche Corleen M. Chief Financial Officer | 2023-06-12 16:58:46 | 58,000 0 | 58,000 | Form 4 |
| Lapetina Bob PAO and VP Finance & Corporate | 2024-01-04 17:40:31 | 52,947 0 | 52,947 | Form 3 |
| Giesing Dennis H Chief Development Officer | 2023-06-12 16:47:24 | 50,000 0 | 50,000 | Form 4 |
| Tsai Philip Chief Technology Officer | 2024-11-25 08:33:23 | 21,000 0 | 21,000 | Form 4 |
| BIENAIME JEAN JACQUES Director | 2024-08-19 21:07:13 | 16,615 0 | 16,615 | Form 4 |
| Lechleider Robert Chief Medical Officer | 2024-11-25 08:35:28 | 15,805 0 | 15,805 | Form 4 |
| WAGENHEIM PHILIP Director | 2024-06-18 20:54:46 | 11,333 0 | 11,333 | Form 4 |
| SWAIN SANDRA M Director | 2024-06-18 20:56:48 | 11,333 0 | 11,333 | Form 4 |
| SCHAFER CAROL Director | 2024-06-18 20:59:41 | 11,333 0 | 11,333 | Form 4 |
| Boylan James P Director | 2024-06-18 21:01:18 | 11,333 0 | 11,333 | Form 4 |
| Marcou Diane M Interim CFO | 2020-12-10 17:26:26 | 8,333 0 | 8,333 | Form 3 |
| Lefenfeld Michael Director | 2023-06-12 16:55:10 | 6,500 0 | 6,500 | Form 4 |
| LAMATTINA JOHN L Director | 2023-06-12 16:54:01 | 6,500 0 | 6,500 | Form 4 |
| BARON RICHARD A Director | 2023-06-12 16:52:28 | 6,500 0 | 6,500 | Form 4 |
| Widlitz Michael Director | 2021-06-01 20:00:05 | 3,750 0 | 3,750 | Form 4 |